● Recruiting

Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State

Condition: Type 1 Diabetes Mellitis · Sponsor: Gan and Lee Pharmaceuticals, USA

PhasePhase 1

Planned participants12

Who can joinAll sexes, 18 Years to 64 Years

Healthy volunteersNo

About this study

This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter referred to as GZR33) and estimate its potency in comparison with insulin degludec.

This description comes directly from the study's public registry record.

Talk to the study team

Andre Feldmann · +49 (0) 2131 4018 409 · 149-1226-GZR-33@profil.com

Always discuss trial participation with your own doctor first.

Locations (2)

Profil Institut	Neuss, Germany	Recruiting
Profil	Neuss, Germany	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07242664